A decade after the KDOQI CKD guidelines: Impact on the cardiovascular disease-CKD paradigm

American Journal of Kidney Diseases

Volumn 60, Issue 5, 2012, Pages 710-712

  Weiner, Daniel E ^a   Sarnak, Mark J ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMINURIA; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; GLOMERULUS FILTRATION RATE; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; MICROALBUMINURIA; PRACTICE GUIDELINE; REVIEW;

EID: 84867522702     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.08.017     Document Type: Editorial

References (23)

1. G. Eknoyan On the epidemic of cardiovascular disease in patients with chronic renal disease and progressive renal failure: a first step to improve the outcomes Am J Kidney Dis 32(5) suppl 3 1998 S1 S4
2. M.J. Sarnak, A.S. Levey Cardiovascular disease and chronic renal disease: a new paradigm Am J Kidney Dis 35(4) suppl 1 2000 S117 S131
3. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification Am J Kidney Dis 39(2) suppl 1 2002 S1 S266
4. National Kidney Foundation Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? Am J Kidney Dis 32(5) suppl 3 1998 S1 S199
5. R.N. Foley, P.S. Parfrey, M.J. Sarnak Clinical epidemiology of cardiovascular disease in chronic renal disease Am J Kidney Dis 32(5) suppl 3 1998 S112 S119
6. M.A. Roberts, K.R. Polkinghorne, S.P. McDonald, F.L. Ierino Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population Am J Kidney Dis 58 1 2011 64 72
7. N.S. Anavekar, J.J. McMurray, E.J. Velazquez Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction N Engl J Med 351 13 2004 1285 1295
8. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 13 2004 1296 1305
9. D.E. Weiner, H. Tighiouart, M.G. Amin Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies J Am Soc Nephrol 15 5 2004 1307 1315
10. H.C. Gerstein, J.F. Mann, Q. Yi Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals JAMA 286 4 2001 421 426
11. H.L. Hillege, V. Fidler, G.F. Diercks Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population Circulation 106 14 2002 1777 1782
12. K. Matsushita, M. van der Velde, B.C. Astor Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 9731 2010 2073 2081
13. M. van der Velde, K. Matsushita, J. Coresh Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality A collaborative meta-analysis of high-risk population cohorts Kidney Int 79 12 2011 1341 1352
14. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 25 2002 3143 3421
15. M.J. Sarnak, A.S. Levey, A.C. Schoolwerth Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation 108 17 2003 2154 2169
16. A.V. Chobanian, G.L. Bakris, H.R. Black Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 42 6 2003 1206 1252
17. D.E. Weiner, H. Tighiouart, J.L. Griffith Kidney disease, Framingham risk scores, and cardiac and mortality outcomes Am J Med 120 6 2007 552 e1-e8
18. A. Rashidi, A.R. Sehgal, M. Rahman, A.S. O'Connor The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years Am J Cardiol 102 12 2008 1668 1673
19. M. Tonelli, P. Muntner, A. Lloyd Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study Lancet 380 9844 2012 807 814
20. R.L. Jamison, P. Hartigan, J.S. Kaufman Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial JAMA 298 10 2007 1163 1170
21. C. Baigent, M.J. Landray, C. Reith The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Lancet 377 9784 2011 2181 2192
22. A.G. Bostom, M.A. Carpenter, J.W. Kusek Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation Trial Circulation 123 16 2011 1763 1770
23. M.A. Pfeffer, E.A. Burdmann, C.Y. Chen A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease N Engl J Med 361 21 2009 2019 2032